Exoplus Bio Group — Regulatory Assets

Patents & Certification

Strategic foresight in regulatory compliance and product documentation — patents, GMP certification and market registrations across eight jurisdictions, presented as a single regulatory board.

Exoplus Bio Group patents and certification board — ISO 22716 GMP certificate, Japanese and Swiss patents, MFDS, NPRA, Health Canada and FDA regulatory assets

Official board — 1672 × 618 source document

Index

Every asset on the board, at a glance

Taiwan

ISO 22716:2007 — Cosmetics GMP

Certificate of scope for the manufacture of liquid and powder cosmetic products. Certificate No. TW007795, version 1, issued 12-01-2020. Manufacture/production cycle 15-01-2019 through 14-01-2025.

Japan

Patent certificate — JP6188249

Granted patent certificate No. JP6188249 (日本專利證書), covering the group's exosome platform technology in the Japanese market.

Switzerland

Patent certificate — CH710255

Swiss patent certificate (瑞士專利證書 CH710255) — for skin care (用於皮膚護理). Issued as Urkunde · Certificat · Certificato 710255.

Switzerland

Patent certificate — CH710157

Swiss patent certificate (瑞士專利證書 CH710157) — promote hair improvement.

South Korea

MFDS cosmetic registration

Manufactured with a Korean medical-equipment partner into a cosmetic skin booster, registered in the cosmetics category with Korea's Ministry of Food and Drug Safety (MFDS) and marketed domestically.

Malaysia

NPRA cosmetic registration

Cosmetic registration approval from Malaysia's National Pharmaceutical Regulatory Agency (NPRA), opening Southeast-Asian skin, hair and chronic-wound health-care markets.

Canada

Cosmetic Notification Form

Cosmetic Notification Form filed with Health Canada. A CNF is a regulatory notification required before sale in Canada — it is not a Health Canada product approval.

United States

FDA listing

U.S. Food & Drug Administration, and the first company in its category to secure dual MOHW (Taiwan) approvals.

Certification and regulatory images are presented as supporting materials for discussion and verification. Manufacturer certificates document scope of certification and patent grants only — they are not Health Canada or FDA product authorizations, and no therapeutic claims are made or implied.

Professional review before publication of any claim

Exoplus Bio

Elevate Your Aesthetics. Trust in Science. Advanced cosmetic formulas supporting healthy-looking skin and hair through clinical exosome science.

Exoplus Bio products are compliant with the Cosmetic Regulations under the Food and Drugs Act of Canada. All products distributed by Exoplus Bio in Canada have been duly notified to Health Canada via the Cosmetic Notification Form (CNF) process. These products are intended for topical, cosmetic use only to enhance skin appearance and are not Health Canada-approved 'Drugs' or 'Natural Health Products' (NHP) with therapeutic claims, unless explicitly stated otherwise with a valid DIN or NPN. Exoplus Bio makes no claims regarding the permanent alteration of body functions.

© 2026 Exoplus Bio — All rights reservedCosmetic use only · Not a drug